These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12061769)

  • 1. Hormonal induction of hepatic mitochondrial ornithine/citrulline transporter mRNA.
    Morris SM; Kepka-Lenhart D
    Biochem Biophys Res Commun; 2002 Jun; 294(4):749-52. PubMed ID: 12061769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of messenger ribonucleic acid levels for five urea cycle enzymes in cultured rat hepatocytes. Requirements for cyclic adenosine monophosphate, glucocorticoids, and ongoing protein synthesis.
    Nebes VL; Morris SM
    Mol Endocrinol; 1988 May; 2(5):444-51. PubMed ID: 2843756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinate induction of the urea cycle enzymes by glucagon and dexamethasone is accomplished by three different mechanisms.
    Ulbright C; Snodgrass PJ
    Arch Biochem Biophys; 1993 Mar; 301(2):237-43. PubMed ID: 8460937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome is caused by mutations in a gene encoding a mitochondrial ornithine transporter.
    Camacho JA; Obie C; Biery B; Goodman BK; Hu CA; Almashanu S; Steel G; Casey R; Lambert M; Mitchell GA; Valle D
    Nat Genet; 1999 Jun; 22(2):151-8. PubMed ID: 10369256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of L-ornithine uptake and L-citrulline and urea biosynthesis by D-arginine.
    Saavedra-Molina A; Piña E
    Biochem Int; 1991 May; 24(2):349-57. PubMed ID: 1930251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of dexamethasone and beta-adrenergic receptor agonists on the nerve growth factor gene transcription.
    Colangelo AM; Mallei A; Johnson PF; Mocchetti I
    Brain Res Mol Brain Res; 2004 May; 124(2):97-104. PubMed ID: 15135217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of c-fos and c-myc protooncogenes by estrogens, xenobiotics and other growth-stimulatory agents in primary rat hepatocytes.
    Lee CH; Edwards AM
    Arch Toxicol; 2003 Mar; 77(3):150-9. PubMed ID: 12632255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of NAD(P)H:quininone oxidoreductase by glucocorticoids.
    Pinaire JA; Xiao GH; Falkner KC; Prough RA
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):344-53. PubMed ID: 15364549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dexamethasone and dibutyryl cAMP on stanniocalcin-1 mRNA expression in rat primary Sertoli and Leydig cells.
    Li L; Wong CK
    Mol Cell Endocrinol; 2008 Feb; 283(1-2):96-103. PubMed ID: 18187254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of mRNA levels for five urea cycle enzymes in rat liver by diet, cyclic AMP, and glucocorticoids.
    Morris SM; Moncman CL; Rand KD; Dizikes GJ; Cederbaum SD; O'Brien WE
    Arch Biochem Biophys; 1987 Jul; 256(1):343-53. PubMed ID: 3038025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of synthetic glucocorticoid, dexamethasone on CYP1A1 inducibility in adult rat and human hepatocytes.
    Monostory K; Kohalmy K; Prough RA; Kóbori L; Vereczkey L
    FEBS Lett; 2005 Jan; 579(1):229-35. PubMed ID: 15620718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of three mitochondrial solute carriers, citrin, aralar1 and ornithine transporter, in relation to urea cycle in mice.
    Begum L; Jalil MA; Kobayashi K; Iijima M; Li MX; Yasuda T; Horiuchi M; del Arco A; Satrústegui J; Saheki T
    Biochim Biophys Acta; 2002 Apr; 1574(3):283-92. PubMed ID: 11997094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A possible rate limiting factor in urea synthesis by isolated hepatocytes: the transport of ornithine into hepatocytes and mitochondria.
    Metoki K; Hommes FA
    Int J Biochem; 1984; 16(11):1155-7. PubMed ID: 6526132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome with evidence of mitochondrial dysfunction due to a novel SLC25A15 (ORNT1) gene mutation in a Palestinian family.
    Korman SH; Kanazawa N; Abu-Libdeh B; Gutman A; Tsujino S
    J Neurol Sci; 2004 Mar; 218(1-2):53-8. PubMed ID: 14759633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of yeast mitochondria to study the properties of wild-type and mutant human mitochondrial ornithine transporter.
    Morizono H; Woolston JE; Colombini M; Tuchman M
    Mol Genet Metab; 2005 Dec; 86(4):431-40. PubMed ID: 16256388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic hormones regulate insulin-like growth factor binding protein-1 mRNA levels in primary cultured salmon hepatocytes; lack of inhibition by insulin.
    Pierce AL; Shimizu M; Felli L; Swanson P; Dickhoff WW
    J Endocrinol; 2006 Nov; 191(2):379-86. PubMed ID: 17088407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone.
    Dolinsky VW; Douglas DN; Lehner R; Vance DE
    Biochem J; 2004 Mar; 378(Pt 3):967-74. PubMed ID: 14662008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of human ORNT2: a second mitochondrial ornithine transporter that can rescue a defective ORNT1 in patients with the hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, a urea cycle disorder.
    Camacho JA; Rioseco-Camacho N; Andrade D; Porter J; Kong J
    Mol Genet Metab; 2003 Aug; 79(4):257-71. PubMed ID: 12948741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes.
    Richert L; Tuschl G; Abadie C; Blanchard N; Pekthong D; Mantion G; Weber JC; Mueller SO
    Toxicol Appl Pharmacol; 2009 Feb; 235(1):86-96. PubMed ID: 19118567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone protects primary cultured hepatocytes from death receptor-mediated apoptosis by upregulation of cFLIP.
    Oh HY; Namkoong S; Lee SJ; Por E; Kim CK; Billiar TR; Han JA; Ha KS; Chung HT; Kwon YG; Lee H; Kim YM
    Cell Death Differ; 2006 Mar; 13(3):512-23. PubMed ID: 16167066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.